Cargando…

Salivary Cytokines in patients with Head and Neck Cancer (HNC) treated with Radiotherapy

BACKGROUND: Head and Neck cancer (HNC) is the sixth most common cancer in the world. The 5-year survival rate depends on early diagnosis and appropriate therapy. Typically, late diagnosis requires not only surgical intervention, but also radiotherapy treatment combined or not with chemotherapy. Ioni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Principe, Sara, Dikova, Valentina, Bagán, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medicina Oral S.L. 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825732/ https://www.ncbi.nlm.nih.gov/pubmed/31700580 http://dx.doi.org/10.4317/jced.56318

Ejemplares similares

Salivary inflammatory proteins in patients with oral potentially malignant disorders
por: Dikova, Valentina R., et al.
Publicado: (2019)

Salivary IL-8 as a putative predictive biomarker of radiotherapy response in head and neck cancer patients
por: Principe, Sara, et al.
Publicado: (2021)

Psychosocial Distress of Head Neck Cancer (HNC) Patients Receiving Radiotherapy: A Systematic Review
por: Nayak, Shalini G, et al.
Publicado: (2022)

Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria
por: Oga, Emmanuel A., et al.
Publicado: (2016)

Health-related quality of life up to 1 year after radiotherapy in patients with head and neck cancer (HNC)
por: Loorents, Vera, et al.
Publicado: (2016)

Interventions to improve quality of life (QOL) and/or mood in patients with head and neck cancer (HNC): a review of the evidence
por: Senchak, Jordan J., et al.
Publicado: (2019)

BMSC–HNC Interaction: Exploring Effects on Bone Integrity and Head and Neck Cancer Progression
por: Eichberger, Jonas, et al.
Publicado: (2023)

What are the optimal measures to identify anxiety and depression in people diagnosed with head and neck cancer (HNC): a systematic review
por: Shunmugasundaram, Chindhu, et al.
Publicado: (2020)

Simultaneous Integrated Boost (SIB) vs. Sequential Boost in Head and Neck Cancer (HNC) Radiotherapy: A Radiomics-Based Decision Proof of Concept
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

A meta-analysis of weekly cisplatin versus three weekly cisplatin chemotherapy plus concurrent radiotherapy (CRT) for advanced head and neck cancer (HNC)
por: Guan, Jian, et al.
Publicado: (2016)

Young population awareness of head and neck cancer's (HNC) risk factors, symptoms and prognosis – a pilot survey
por: Krentowska, Anna, et al.
Publicado: (2015)

A Phase Ib study of neoadjuvant immune biomarker modulation with cetuximab and motolimod in head and neck cancer (HNC)
por: Ferris, Robert L, et al.
Publicado: (2015)

Head and neck cancer predictive risk estimator to determine control and therapeutic outcomes of radiotherapy (HNC-PREDICTOR): development, international multi-institutional validation, and web implementation of clinic-ready model-based risk stratification for head and neck cancer
por: van Dijk, Lisanne V., et al.
Publicado: (2023)

Potential Non-Invasive Biomarkers for Early Diagnosis of Oral Squamous Cell Carcinoma
por: Dikova, Valentina, et al.
Publicado: (2021)

Nutritional Deficiencies in Radiotherapy-Treated Head and Neck Cancer Patients
por: Powrózek, Tomasz, et al.
Publicado: (2021)

Cytokine Levels in Saliva Are Associated with Salivary Gland Fibrosis and Hyposalivation in Mice after Fractionated Radiotherapy of the Head and Neck
por: Zlygosteva, Olga, et al.
Publicado: (2023)

Setup errors in patients with head-neck cancer (HNC), treated using the Intensity Modulated Radiation Therapy (IMRT) technique: how it influences the customised immobilisation systems, patient’s pain and anxiety
por: Contesini, Massimiliano, et al.
Publicado: (2017)

Neck Lymph Node Recurrence in HNC Patients Might Be Predicted before Radiotherapy Using Radiomics Extracted from CT Images and XGBoost Algorithm
por: Tsai, Yi-Lun, et al.
Publicado: (2022)

Evaluation of the salivary function of patients in treatment with radiotherapy for head and neck cancer submitted to photobiomodulation
por: Ribeiro, Lucas Nascimento, et al.
Publicado: (2021)

Randomized Phase III Trial of Adjuvant Chemotherapy with S-1 after Curative Treatment in Patients with Squamous-Cell Carcinoma of the Head and Neck (ACTS-HNC)
por: Tsukahara, Kiyoaki, et al.
Publicado: (2015)

Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study
por: Kubota, Akira, et al.
Publicado: (2018)

Adaptive radiotherapy for head and neck cancer
por: Morgan, Howard E., et al.
Publicado: (2020)

Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study
por: Liu, Gang, et al.
Publicado: (2020)

Correlation between Tissue Cellularity and Metabolism Represented by Diffusion-Weighted Imaging (DWI) and 18F-FDG PET/MRI in Head and Neck Cancer (HNC)
por: Freihat, Omar, et al.
Publicado: (2022)

Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy
por: Braam, Pètra M, et al.
Publicado: (2007)

Radiation therapy and serum salivary amylase in head and neck cancer
por: De Felice, Francesca, et al.
Publicado: (2017)

Role of radiotherapy in the treatment of metastatic head and neck cancer
por: Ordoñez, Rafael, et al.
Publicado: (2019)

Development of Prediction Model for Mean Parotid Dose of HNC Undergoing Radiotherapy - A Single Institutional Study
por: Bera, Soumen, et al.
Publicado: (2023)

Feasibility of DW-MRI analysis of salivary glands during head and neck radiotherapy
por: Duffton, Aileen, et al.
Publicado: (2021)

Combining Radiotherapy and Immunotherapy in Head and Neck Cancer
por: Runnels, Juliana, et al.
Publicado: (2023)

The need for supportive care among head and neck cancer patients: psychometric assessment of the Dutch version of the Supportive Care Needs Survey Short-Form (SCNS-SF34) and the newly developed head and neck cancer module (SCNS-HNC)
por: Jansen, Femke, et al.
Publicado: (2016)

Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy
por: Huynh, T. T. M., et al.
Publicado: (2022)

Magnetic Resonance Guided Radiotherapy for Head and Neck Cancers
por: Gharzai, Laila A., et al.
Publicado: (2022)

FMISO-Based Adaptive Radiotherapy in Head and Neck Cancer
por: Dolezel, Martin, et al.
Publicado: (2022)

Radiotherapy and Systemic Therapies: Focus on Head and Neck Cancer
por: De Felice, Francesca, et al.
Publicado: (2023)

Head and Neck Lymphomas in HIV Patients: a Clinical Perspective
por: Oishi, Natsuki, et al.
Publicado: (2017)

Hydrogen bonding capabilities of group 14 homologues of HCN and HNC
por: Bautista-Renedo, Joanatan M., et al.
Publicado: (2019)

The role of tumor volume in radiotherapy of patients with head and neck cancer
por: Rutkowski, Tomasz
Publicado: (2014)

Salivary and crevicular fluid interleukins in gingivitis
por: Boronat-Catalá, Montserrat, et al.
Publicado: (2014)

Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients
por: Brøndum, Line, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dosd9hoafip98ku9h9t7grfsq3